Literature DB >> 29165768

Recent perspectives of pediatric leukemia - an update.

Q An1, C-H Fan, S-M Xu.   

Abstract

Leukemia is defined as an aberrant hyper-proliferation of immature blood cells that do not form solid tumor masses (i.e., liquid cancer). Usually, leukemia could be either of the myeloid or lymphoid lineages, and is classified as acute or chronic in nature. Chronic leukemias tend to have more mature cells and are rare in pediatric patients. Acute leukemias, on the other hand, are typically less mature and commonly occur in patients of all ages and are potentially rapidly fatal if not readily treated. The acute lymphoblastic leukemia (ALL) is the most common childhood malignancy. Similar to AML, and in some cases, on the same disease spectrum, are the myelodysplastic syndromes (MDS). The present review is focused on the recent perspectives of pediatric leukemia.

Entities:  

Mesh:

Year:  2017        PMID: 29165768

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  9 in total

1.  Application of High-Efficiency Cell Expansion and High-Throughput Drug Sensitivity Screening for Leukemia Treatment.

Authors:  Lili Li; Wenliang Wang; Li Liang; Jian Ge; Ruixiang Xia
Journal:  Dis Markers       Date:  2022-07-05       Impact factor: 3.464

Review 2.  Pyroptosis: mechanisms and diseases.

Authors:  Pian Yu; Xu Zhang; Nian Liu; Ling Tang; Cong Peng; Xiang Chen
Journal:  Signal Transduct Target Ther       Date:  2021-03-29

3.  The prognosis biomarkers based on m6A-related lncRNAs for myeloid leukemia patients.

Authors:  Li-Rong Yang; Zhu-Ying Lin; Qing-Gang Hao; Tian-Tian Li; Yun Zhu; Zhao-Wei Teng; Jun Zhang
Journal:  Cancer Cell Int       Date:  2022-01-07       Impact factor: 5.722

4.  The Role of Gender-Related Immune Genes in Childhood Acute Myeloid Leukemia.

Authors:  Lu Hao; Qiuyan Chen; Xi Chen; Qing Zhou
Journal:  Biomed Res Int       Date:  2022-09-23       Impact factor: 3.246

Review 5.  The emerging role of pyroptosis in pediatric cancers: from mechanism to therapy.

Authors:  Hua Wang; Xiaowen Zhou; Chenbei Li; Shuxiang Yan; Chengyao Feng; Jieyu He; Zhihong Li; Chao Tu
Journal:  J Hematol Oncol       Date:  2022-10-08       Impact factor: 23.168

6.  [Prognostic significance and risk factors of minimal residual disease ≥1% on 19th day of induction chemotherapy in children with acute lymphoblastic leukemia].

Authors:  Jieming Yu; Tiantian Yi; Guanchuan Lin; Jianyun Wen; Libai Chen; Jiaqi Chen; Xuedong Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-02-29

7.  ITPA, TPMT, and NUDT15 Genetic Polymorphisms Predict 6-Mercaptopurine Toxicity in Middle Eastern Children With Acute Lymphoblastic Leukemia.

Authors:  Borhan Moradveisi; Samar Muwakkit; Fatemeh Zamani; Ebrahim Ghaderi; Ebrahim Mohammadi; Nathalie K Zgheib
Journal:  Front Pharmacol       Date:  2019-08-27       Impact factor: 5.810

8.  Alternative donor peripheral blood stem cell transplantation for the treatment of high-risk refractory and/or relapsed childhood acute leukemia: a randomized trial.

Authors:  Binglei Zhang; Jian Zhou; Fengkuan Yu; Tianxin Lv; Baijun Fang; Dandan Fan; Zhenyu Ji; Yongping Song
Journal:  Exp Hematol Oncol       Date:  2020-04-06

9.  Seq-SymRF: a random forest model predicts potential miRNA-disease associations based on information of sequences and clinical symptoms.

Authors:  Jinlong Li; Xingyu Chen; Qixing Huang; Yang Wang; Yun Xie; Zong Dai; Xiaoyong Zou; Zhanchao Li
Journal:  Sci Rep       Date:  2020-10-21       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.